MSB 2.51% 97.0¢ mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-84

  1. 303 Posts.
    lightbulb Created with Sketch. 32
    Oh actually yeah I overreacted again. Great news but of course not confirmed. With Big Pharma behind us this time this has to be the time.....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.